Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bitler BG"" wg kryterium: Autor


Tytuł:
Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression.
Autorzy:
Crump LS; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Floyd JL; University of Colorado Denver, Aurora, CO, United States.
Kuo LW; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Post MD; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Bickerdike M; AntidoTherapeutics Pty Ltd, Melbourne, Victoria, Australia.
O'Neill K; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Sompel K; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Jordan KR; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Corr BR; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Marjon N; University of Colorado Denver, Aurora, CO, United States.
Woodruff ER; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Richer JK; University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Bitler BG; University of Colorado Denver, Aurora, CO, United States.
Pokaż więcej
Źródło:
Cancer research communications [Cancer Res Commun] 2024 Mar 07. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers.
Autorzy:
Sottnik JL; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Shackleford MT; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Robinson SK; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Villagomez FR; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Bahnassy S; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Oesterreich S; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Hu J; Biostatistics and Bioinformatics Shared Resource, University of Colorado Cancer Center, Aurora, Colorado.
Madak-Erdogan Z; Department of Food Science and Human Nutrition, Cancer Center at Illinois, Division of Nutritional Sciences, University of Illinois Urbana-Champaign, Champaign, Illinois.
Riggins RB; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Corr BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Cook LS; Department of Epidemiology, University of Colorado School of Public Health, Aurora, Colorado.
Treviño LS; Depratment of Population Sciences, Division of Health Equities, City of Hope, Duarte, California.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Sikora MJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Pokaż więcej
Źródło:
Cancer research communications [Cancer Res Commun] 2024 Jan 17; Vol. 4 (1), pp. 134-151.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genital Neoplasms, Female*/genetics
Breast Neoplasms*/genetics
Humans ; Female ; Ligands ; AMP-Activated Protein Kinases/metabolism ; Signal Transduction ; Wnt4 Protein/genetics ; Carbonyl Reductase (NADPH)/metabolism
Czasopismo naukowe
Tytuł:
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma.
Autorzy:
Bitler BG; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado School of Medicine, Aurora, Colorado, USA.
Bailey CA; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado School of Medicine, Aurora, Colorado, USA.
Yamamoto TM; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado School of Medicine, Aurora, Colorado, USA.
McMellen A; Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine, Aurora, Colorado, USA.
Kim H; Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Watson ZL; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado School of Medicine, Aurora, Colorado, USA.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2023 Nov; Vol. 62 (11), pp. 1717-1730. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Female ; Humans ; Cell Line, Tumor ; Histones/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology
Czasopismo naukowe
Tytuł:
SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data.
Autorzy:
Seal S; Department of Public Health Sciences, School of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Bitler BG; Department of Obstetrics and Gynecology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States of America.
Ghosh D; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States of America.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2023 Oct 20; Vol. 19 (10), pp. e1010983. Date of Electronic Publication: 2023 Oct 20 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Transcriptome*/genetics
Gene Expression Profiling*
Computer Simulation
Czasopismo naukowe
Tytuł:
A platform-independent framework for phenotyping of multiplex tissue imaging data.
Autorzy:
Ahmadian M; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Rickert C; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Minic A; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Wrobel J; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Bitler BG; Division of Reproductive Sciences, Department of OB/GYN, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Xing F; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Angelo M; Department of Pathology, Stanford University, Stanford, California, United States of America.
Hsieh EWY; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.; Pediatrics, Section of Allergy and Immunology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Ghosh D; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Jordan KR; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Sep 21; Vol. 19 (9), pp. e1011432. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Image Processing, Computer-Assisted*/methods
Tomography, X-Ray Computed*/methods
Artifacts ; Signal-To-Noise Ratio ; Algorithms
Czasopismo naukowe
Tytuł:
Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tube.
Autorzy:
Johnson J; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Aurora, Colorado, USA.
Kim SY; Department of Obstetrics and Gynecology, College of Medicine, Olson Center for Women's Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Sam PK; University of Colorado-Boulder, Boulder, Colorado, USA.
Asokan R; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Cari EL; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Aurora, Colorado, USA.
Bales ES; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Luu TH; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Aurora, Colorado, USA.
Perez L; University of California-Los Angeles, Los Angeles, California, USA.
Kallen AN; Yale School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, New Haven, Connecticut, USA.
Nel-Themaat L; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Aurora, Colorado, USA.; Shady Grove Fertility - Colorado, Denver, Colorado, USA.
Polotsky AJ; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Aurora, Colorado, USA.; Shady Grove Fertility - Colorado, Denver, Colorado, USA.
Post MD; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Orlicky DJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Jordan KR; Department of Immunology and Microbiology, Human Immunology and Immunotherapy Initiative, Human Immune Monitoring Shared Resource, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Bitler BG; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Pokaż więcej
Źródło:
American journal of reproductive immunology (New York, N.Y. : 1989) [Am J Reprod Immunol] 2023 Mar; Vol. 89 (3), pp. e13649. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Fallopian Tubes*
Ovary*
Programmed Cell Death 1 Receptor*/metabolism
Female ; Humans ; B7-H1 Antigen/metabolism ; Carcinogenesis ; Ligands ; T-Lymphocytes
Czasopismo naukowe
Tytuł:
Claudin-4 localization in epithelial ovarian cancer.
Autorzy:
Neville MC; Departments of Obstetrics and Gynecology and Physiology and Biophysics, University of Colorado School of Medicine, Aurora, CO, 80845, USA.
Webb PG; Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80845, USA.
Baumgartner HK; University of Colorado Anschutz Medical Campus, 2700 E. 19th Ave., Aurora, CO, 80045, USA.
Bitler BG; Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Denver Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19 Ave., Aurora, CO, 80045, USA.
Pokaż więcej
Źródło:
Heliyon [Heliyon] 2022 Oct 04; Vol. 8 (10), pp. e10862. Date of Electronic Publication: 2022 Oct 04 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
On clustering for cell-phenotyping in multiplex immunohistochemistry (mIHC) and multiplexed ion beam imaging (MIBI) data.
Autorzy:
Seal S; Department of Biostatistics and Informatics, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA. .
Wrobel J; Department of Biostatistics and Informatics, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Johnson AM; Department of Medicine, School of Medicine, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Nemenoff RA; Department of Medicine, School of Medicine, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Schenk EL; Division of Medical Oncology, School of Medicine, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Bitler BG; Department of Obstetrics and Gynecology, School of Medicine, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Jordan KR; Department of Immunology and Microbiology, School of Medicine, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Ghosh D; Department of Biostatistics and Informatics, University of Colorado CU Anschutz Medical Campus, Aurora, Colorado, USA.
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2022 Jun 20; Vol. 15 (1), pp. 215. Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Diagnostic Imaging*
Cluster Analysis ; Flow Cytometry ; Immunohistochemistry
Czasopismo naukowe
Tytuł:
SPF: A spatial and functional data analytic approach to cell imaging data.
Autorzy:
Vu T; Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Wrobel J; Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Bitler BG; University of Colorado Comprehensive Cancer Center, Aurora, Colorado, United States of America.; Department of OB/GYN, Division of Reproductive Sciences, The University of Colorado, Aurora, Colorado, United States of America.
Schenk EL; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Jordan KR; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Ghosh D; Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2022 Jun 15; Vol. 18 (6), pp. e1009486. Date of Electronic Publication: 2022 Jun 15 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Data Science ; Humans ; Immunohistochemistry ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Autorzy:
Moroney MR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Woodruff E; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Qamar L; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Bradford AP; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Wolsky R; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Bitler BG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Corr BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2021 Aug; Vol. 60 (8), pp. 511-523. Date of Electronic Publication: 2021 May 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Endometrial Neoplasms/*genetics
Endometrial Neoplasms/*metabolism
Wnt Proteins/*metabolism
Wnt Signaling Pathway/*drug effects
beta Catenin/*metabolism
Cell Line, Tumor ; Cell Survival ; Disease Management ; Disease Susceptibility ; Endometrial Neoplasms/drug therapy ; Endometrial Neoplasms/pathology ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Heterocyclic Compounds, 3-Ring/pharmacology ; Humans ; Imidazoles/pharmacology ; Indazoles/pharmacology ; Molecular Targeted Therapy ; Pyridines/pharmacology ; Recurrence ; beta Catenin/genetics
Czasopismo naukowe
Tytuł:
Decoding the dynamic tumor microenvironment.
Autorzy:
Clauset A; Department of Computer Science, University of Colorado Boulder, Boulder, CO 80309, USA.; Santa Fe Institute, Santa Fe, NM 87501, USA.; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80309, USA.
Behbakht K; University of Colorado Cancer Center, Aurora, CO 80045, USA.; Department of OB/GYN, Division of Gynecologic Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Department of OB/GYN, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Bitler BG; University of Colorado Cancer Center, Aurora, CO 80045, USA. benjamin.bitler@cuanschutz.edu.; Department of OB/GYN, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Pokaż więcej
Źródło:
Science advances [Sci Adv] 2021 Jun 04; Vol. 7 (23). Date of Electronic Publication: 2021 Jun 04 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Assessing Genetic Variants in Matched Biocompartments From Patients With Serous Ovarian Cancer.
Autorzy:
Sanders BE; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Ku L; Division of Oncology, Department of Medicine, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Walker P; Circulogene, Birmingham, AL, USA.
Bitler BG; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.; Division of Reproductive Sciences, Department of Obstetrics & Gynecology, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Pokaż więcej
Źródło:
Technology in cancer research & treatment [Technol Cancer Res Treat] 2021 Jan-Dec; Vol. 20, pp. 15330338211027917.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Ascites/*genetics
Neoplasms, Cystic, Mucinous, and Serous/*genetics
Neoplasms, Cystic, Mucinous, and Serous/*metabolism
Ovarian Neoplasms/*genetics
Ovarian Neoplasms/*metabolism
Aged ; Aged, 80 and over ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Female ; Gene Frequency ; Genetic Testing ; Germ-Line Mutation ; Humans ; Middle Aged ; Neoplasms, Cystic, Mucinous, and Serous/blood ; Ovarian Neoplasms/blood ; Sequence Analysis, DNA ; Tumor Suppressor Protein p53/genetics ; Vascular Endothelial Growth Factor Receptor-2/genetics
Czasopismo naukowe
Tytuł:
Wnt Signaling in Gynecologic Malignancies.
Autorzy:
McMellen A; Department of OB/GYN, Division of Reproductive Sciences, The University of Colorado, Aurora, CO 80045, USA.
Woodruff ER; Department of OB/GYN, Division of Reproductive Sciences, The University of Colorado, Aurora, CO 80045, USA.
Corr BR; Department of OB/GYN, Division of Gynecologic Oncology, The University of Colorado, Aurora, CO 80045, USA.; University of Colorado Comprehensive Cancer Center, Aurora, CO 80045, USA.
Bitler BG; Department of OB/GYN, Division of Reproductive Sciences, The University of Colorado, Aurora, CO 80045, USA.; University of Colorado Comprehensive Cancer Center, Aurora, CO 80045, USA.
Moroney MR; Department of OB/GYN, Division of Gynecologic Oncology, The University of Colorado, Aurora, CO 80045, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Jun 16; Vol. 21 (12). Date of Electronic Publication: 2020 Jun 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Wnt Signaling Pathway*
Endometrial Neoplasms/*metabolism
Ovarian Neoplasms/*metabolism
Uterine Cervical Neoplasms/*metabolism
Antineoplastic Agents/therapeutic use ; Disease Progression ; Drug Resistance, Neoplasm ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł:
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
Autorzy:
Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
McMellen A; Cancer Biology Graduate Program, University of Colorado, Aurora, CO, 80045, USA.
Kim H; Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Hughes CJ; Medical Student Training Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Wheeler LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Post MD; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Behbakht K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80045, USA. benjamin.bitler@ucdenver.edu.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2019 Nov 27; Vol. 11 (1), pp. 165. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Neoplasm*
Cystadenocarcinoma, Serous/*genetics
Histocompatibility Antigens/*genetics
Histone-Lysine N-Methyltransferase/*genetics
Ovarian Neoplasms/*genetics
Phthalazines/*pharmacology
Piperazines/*pharmacology
Poly(ADP-ribose) Polymerase Inhibitors/*pharmacology
Animals ; Cell Line, Tumor ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/pathology ; Disease Progression ; Female ; Gene Expression Profiling/methods ; Histones/metabolism ; Humans ; Mass Spectrometry ; Mice ; Neoplasm Grading ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Sequence Analysis, RNA ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
Autorzy:
Ramzan AA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12631 East 17th Avenue B198-6, Aurora, CO, 80045, USA. .
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Hicks D; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Barner K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Qamar L; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Behbakht K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12631 East 17th Avenue B198-6, Aurora, CO, 80045, USA.
Powell T; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Jansson T; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Wilson H; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA.
Pokaż więcej
Źródło:
Molecular and cellular biochemistry [Mol Cell Biochem] 2019 Nov; Vol. 461 (1-2), pp. 37-46. Date of Electronic Publication: 2019 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Apoptosis/*drug effects
Ovarian Neoplasms/*pathology
Piperidines/*pharmacology
Receptors, Adiponectin/*agonists
AMP-Activated Protein Kinases/metabolism ; Cell Cycle Checkpoints/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Female ; Humans ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Mitosis/drug effects ; Models, Biological ; Neoplasm Grading ; Neoplasms, Cystic, Mucinous, and Serous/enzymology ; Neoplasms, Cystic, Mucinous, and Serous/pathology ; Ovarian Neoplasms/enzymology ; Receptors, Adiponectin/metabolism
Czasopismo naukowe
Tytuł:
Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Autorzy:
Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
McMellen A; Cancer Biology Graduate Program, The University of Colorado, Aurora, Colorado.
Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Aguilera J; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Ferguson R; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Nurmemmedov E; John Wayne Cancer Center, Los Angeles, California.
Thakar T; Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Moldovan GL; Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Kim H; Division of Medical Oncology, Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Cittelly DM; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Joglar AM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Brennecke EP; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Wilson H; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Behbakht K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Sikora MJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2019 Oct; Vol. 58 (10), pp. 1770-1782. Date of Electronic Publication: 2019 Jun 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Ovarian Neoplasms/*drug therapy
Phthalazines/*pharmacology
Piperazines/*pharmacology
Poly(ADP-ribose) Polymerase Inhibitors/*pharmacology
Poly(ADP-ribose) Polymerases/*genetics
Animals ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Heterografts ; Humans ; Indazoles/pharmacology ; Indoles/pharmacology ; Mice ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Piperidines/pharmacology ; Wnt Signaling Pathway/drug effects
Czasopismo naukowe
Tytuł:
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination.
Autorzy:
Wheeler LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12700 E. 19(th) Avenue, MS 8613, Aurora, CO 80045, USA.
Qamar L; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12700 E. 19(th) Avenue, MS 8613, Aurora, CO 80045, USA.
Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12700 E. 19(th) Avenue, MS 8613, Aurora, CO 80045, USA.
Sawyer BT; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Sullivan KD; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Khanal S; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Joshi M; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Ferchaud-Roucher V; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Smith H; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Vanderlinden LA; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Brubaker SW; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Caino CM; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Kim H; Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Espinosa JM; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Richer JK; Department of Pathology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12700 E. 19(th) Avenue, MS 8613, Aurora, CO 80045, USA. Electronic address: benjamin.bitler@ucdenver.edu.
Pokaż więcej
Źródło:
IScience [iScience] 2019 Sep 27; Vol. 19, pp. 474-491. Date of Electronic Publication: 2019 Aug 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Autorzy:
Gordon MA; Department of Pathology, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Babbs B; Department of Pathology, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Cochrane DR; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, Canada.
Bitler BG; Department of Pathology, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Richer JK; Department of Pathology, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2019 Feb; Vol. 58 (2), pp. 196-205. Date of Electronic Publication: 2018 Oct 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alternative Splicing*
Gene Expression Profiling/*methods
Ovarian Neoplasms/*genetics
RNA Splicing Factors/*genetics
RNA, Long Noncoding/*genetics
Repressor Proteins/*genetics
Anoikis ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Disease Progression ; Epithelial-Mesenchymal Transition ; Female ; Gene Amplification ; Gene Expression Regulation, Neoplastic ; Humans ; Up-Regulation
Czasopismo naukowe
Tytuł:
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
Autorzy:
Wheeler LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Qamar L; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Post MD; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Berning AA; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Spillman MA; Gynecologic Oncology, Texas A&M University Medical School, Baylor University Medical Center, Dallas, TX, USA.
Behbakht K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. benjamin.bitler@ucdenver.edu.
Pokaż więcej
Źródło:
Oncogenesis [Oncogenesis] 2018 Nov 26; Vol. 7 (11), pp. 92. Date of Electronic Publication: 2018 Nov 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells.
Autorzy:
Wu S; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Fatkhutdinov N; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.; Kazan Federal University, Kazan, 420008, Russia.
Fukumoto T; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Bitler BG; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Park PH; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Kossenkov AV; Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, PA, 19104, USA.
Trizzino M; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Tang HY; Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, PA, 19104, USA.
Zhang L; Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Gardini A; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Speicher DW; Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, PA, 19104, USA.; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, 19104, USA.
Zhang R; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2018 Oct 08; Vol. 9 (1), pp. 4116. Date of Electronic Publication: 2018 Oct 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Chromosomal Proteins, Non-Histone/*metabolism
Drug Resistance, Neoplasm/*drug effects
Enhancer of Zeste Homolog 2 Protein/*antagonists & inhibitors
Indoles/*pharmacology
Nuclear Proteins/*metabolism
Pyridones/*pharmacology
Transcription Factors/*metabolism
Aniline Compounds/administration & dosage ; Animals ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Cell Line, Tumor ; Chromosomal Proteins, Non-Histone/genetics ; DNA Helicases/genetics ; DNA Helicases/metabolism ; DNA-Binding Proteins ; Drug Resistance, Neoplasm/genetics ; Enhancer of Zeste Homolog 2 Protein/genetics ; Enhancer of Zeste Homolog 2 Protein/metabolism ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Indoles/administration & dosage ; Mice, Inbred NOD ; Mice, Knockout ; Mice, SCID ; Mutation ; Nuclear Proteins/genetics ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Pyridones/administration & dosage ; Sulfonamides/administration & dosage ; Transcription Factors/genetics ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays/methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies